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ABSTRACT
Background: Cow’s milk allergy (CMA) is one of the causes of gastrointestinal symptoms in neonates. A rela-
tionship between non-immunoglobulin (Ig) E mediated allergic reactions and CMA in early infancy has been
proposed, but the clinical features and pathogenesis have not been established. The objective of this study is
to determine the clinical characteristics of the neonates found in the earlier study to have food-related symp-
toms that suggested CMA.
Methods: A second questionnaire was sent to 53 NICUs, as a follow-up to the earlier study, to collect informa-
tion on the background, onset age, clinical features, and results of clinical examinations.
Results: The median birth weight was 2614 g and the median gestational age was 36.9 weeks. Symptoms de-
veloped within 6 days after birth in 40% of cases. Gastrointestinal symptoms were seen in 90% of cases and
were mainly vomiting, bloody stool and abdominal distention. A specific IgE test, a lymphocyte stimulation test,
and a fecal eosinophil test were conducted in 88%, 23% and 55% of cases, respectively, and the positive rates
were 30%, 84%, and 75%, respectively. An oral food challenge (OFC) test was performed in 26% for confirma-
tion of the diagnosis.
Conclusions: We confirmed that the clinical manifestations of food-related symptoms suggestive of CMA in
neonates were distinctly different from those of common immediate type food allergy and were largely affected
by underlying factors such as prematurity and gastroenterological surgery. Further OFC-based prospective ac-
cumulation of cases of CMA in neonates will be particularly important to reveal the full clinical features of this
disease.
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INTRODUCTION
In neonates, gastrointestinal symptoms are common
and suggest disorders such as congenital anomaly of
the gastrointestinal tract, infection, metabolic disease,
and allergic disease. If these symptoms develop after
intake of milk formula, involvement of allergic reac-
tions to cow’s milk protein may be suspected. Cow’s
milk allergy (CMA) presents with a variety of symp-
toms and is a common cause of gastrointestinal symp-
toms such as diarrhea, vomiting, and bloody stool in
the neonatal period.1,2 However, these symptoms are
not specific to CMA, which makes an accurate diag-
nosis extremely difficult. A relationship between non-
immunoglobulin (Ig) E-mediated delayed type aller-
gic reactions and CMA in early infancy has been pro-
posed, but the clinical features and pathogenesis
have not been fully established.2-4
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In the field of neonatal medicine, an oral food chal-
lenge (OFC) test for suspected CMA tends to be
avoided because of concern regarding induction of
severe symptoms, and standardized diagnostic crite-
ria for CMA are not available. Therefore, a definite di-
agnosis of CMA is rare and epidemiological studies
have not been performed due to a lack of accumula-
tion of cases. We previously reported that the inci-
dence of cases with food-related symptoms that sug-
gested CMA was 0.21% (14569,796) in neonatal care
units (NICUs) in Japan and that most NICUs cur-
rently make a diagnosis and establish treatment
strategies based on observation of the clinical course,
rather than performing an OFC.5 In this study, we
retrospectively evaluated clinical data for these identi-
fied neonates presenting with food-related symptoms
suggestive of CMA.
METHODS
We distributed a primary questionnaire to 263 NICUs
to obtain information on the number of hospitalized
neonates and the number of cases with food-related
symptoms suggestive of CMA between January 2004
and December 2005. Of the 263 NICUs, 145 re-
sponded to the questionnaire and 53 of these had at
least one case with food-related symptoms suggestive
of CMA. These NICUs are certified as educational in-
stitutions by the Japan Society of Perinatal and Neo-
natal Medicine. The inclusion criteria did not require
performance of an OFC, because it was assumed that
an OFC would be avoided by most neonatologists
due to fear of induction of severe symptoms. All the
subjects had food-related symptoms that suggested
CMA based on the results of clinical examinations
and positive results in milk elimination tests: that is,
disappearance of symptoms after elimination of milk,
and no recurrence of symptoms and normal weight
gain after initiation of feeding with therapeutic for-
mula.
A second questionnaire was mailed to the 53 NI-
CUs to request information on background, onset
age, clinical features, and the results of clinical exami-
nations for the 145 neonates. Specific IgE levels were
all determined by an ImmunoCAP assay (Phadia K.
K., Tokyo, Japan). Data were analyzed by Mann-
Whitney U test, Fisher exact test and Student t-test.
The level of significance was p < 0.05. Statistical
analysis was performed using PASW Statistics ver.18.
The study was approved by the Ethics Committee of
Showa University School of Medicine and was per-
formed with consideration of all appropriate ethical is-
sues.
RESULTS
PATIENT BACKGROUND
Of the 53 NICUs, 38 (72%) responded to the second
questionnaire and data were collected for 111 cases
(77%). The median birth weight in the 111 subjects
was 2614 g (406-3936 g), the median gestational age
was 36.9 weeks (range: 25.3-42.0 weeks), and the
male-to-female ratio was 1.5. There were 45 low birth
weight infants (41%), including 9 with birth weight
<1000 g and 4 with birth weight 1000-1500 g. The inci-
dence of complications was 51% (57111), including
32 cases (29%) with respiratory disease, 17 (15%) with
infection, 13 (12%) with gastrointestinal disease, 6
(5%) with heart disease, and 3 (3%) with a chromoso-
mal aberration; these data include multiple re-
sponses. Surgery was performed in 12 cases (11%)
before onset, including 10 with gastrointestinal dis-
ease (3 with gastrointestinal atresia, 2 with Hirsch-
sprung disease, 2 with congenital diaphragmatic her-
nia, 1 with idiopathic perforation of the ileum, 1 with
necrotising enterocolitis, and 1 with exomphalos) and
2 cases of congenital heart disease (1 of coarctation of
the aorta and 1 of univentricular heart complicated by
coarctation of the aorta).
ONSET AGE AND FEEDING AT ONSET
The median onset age was 7 days (range: 0-67 days)
in 109 cases for which records were available. Of
these cases, 44 (40%) developed food-related symp-
toms within 6 days after birth. The feeding at onset
was exclusively breastfeeding in 18 of the 111 cases
(16%), complementary feeding in 60 cases (54%), for-
mula feeding in 26 (23%), MCT (medium chain tri-
glycerides) milk in 2 (2%), and breast milk with hu-
man milk fortifier in 1 (1%). Onset occurred before
starting lactation in 2 cases (2%) and the feeding in
another 2 cases (2%) was unknown.
CLINICAL MANIFESTATIONS
Gastrointestinal symptoms occurred in 90% of sub-
jects and were mainly vomiting, bloody stool and ab-
dominal distension (Fig. 1). Failure to thrive and sys-
temic symptoms such as fever, hypothermia and not
doing well occurred frequently. A few neonates also
presented with shock symptoms, cutaneous symp-
toms or respiratory symptoms, which are frequently
seen in immediate food hypersensitivity.
LABORATORY FINDINGS
Specific IgE for milk allergens were tested in 98 cases
(88%). Of these cases, 25 (26%) and 29 (30%) had spe-
cific IgE values of >0.70 UAml (>class 2) and >0.35
UAml (>class 1), respectively. A lymphocyte stimu-
lation test (LST) was performed in 25 cases (23%) and
the positive rate was 84% (2125). Specific IgE was
negative in 20 of these 21 cases and not tested in the
remaining case; that is, no neonates were identified
who were positive in a LST and a specific IgE test. A
fecal eosinophil test was performed in 61 cases (55%)
and was positive in 46 (75%). Among 98 cases in
which food-related symptoms developed within 1
month after birth, an OFC was conducted in 25 (26%)
to confirm the diagnosis.
Food-Related Symptoms in Neonates
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Fig.　1　Clinical manifestations in 111 neonates. The incidences of symptoms are shown as percentages. 
The vertical bar chart shows the incidence of each gastrointestinal symptom.
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Table　1　Results of blood tests
Item n Median Range
White blood cells (/μl) 99 12100 2900-51100
Eosinophils (/μl) 98 814 0-10000
CRP (mg/dl) 100 0.54 0.00-15.00
AST (IU/l) 85 30 9-413
ALT (IU/l) 86 11 1-482
γGTP (IU/l) 25 179 36-689
Table　2　Onset age of symptoms (days)
Birth weight n Average (±SD) Median (range)
<1000 g 9 22.2 ± 13.4 14.5 (9-47)
1000-1500 g 4 15.0 ± 8.2 13.5 (7-26)
1500-2500 g 31 10.7 ± 10.2 7 (1-43)*
>2500 g 65 9.6 ± 13.1 6 (0-67)*
Total 109 11.2 ± 12.6 7 (0-67)
Neonates with birth weight <1000 g tended to develop symp-
toms signifi cantly later than those with birth weight >1500 g or 
>2500 g.
*p < 0.05 (Mann-Whitney U test) vs. birth weight <1000 g.
The results of other common blood tests are
shown in Table 1. Some neonates had an increase in
CRP similar to that seen in sepsis. Those with high
CRP (>4.0 mgdl, n = 14) had systemic symptoms
such as fever (21%) and not doing well (43%), as well
as gastrointestinal symptoms. Eosinophilia (>700μl)
was present in about half of the neonates, but there
were no differences in clinical features or in the posi-
tive rate of fecal eosinophils in neonates with and
without eosinophilia.
PATIENT BACKGROUNDS AND CLINICAL FEA-
TURES
Neonates with birth weight <1000 g tended to de-
velop food-related symptoms significantly later com-
pared to those with birth weight >1500 g or >2500 g
(Table 2). Neonates with a smaller birth weight had
higher incidences of diarrhea and increased gastric
residual, and lower incidences of vomiting and bloody
stool (Fig. 2). No neonates with birth weight <1000 g
developed bloody stool, but the incidence of in-
creased gastric residual (67%) and failure to thrive
(56%) were significantly higher than those in other
groups (p < 0.05). There were no significant differ-
ences in the results of the specific IgE test, LST and
fecal eosinophil test among the groups.
The incidence of bloody stool was significantly
higher in neonates who developed symptoms within
6 days after birth (early onset group, n = 44) than in
those who developed symptoms after 7 days after
birth (late onset group, n = 55). In contrast, the late
onset group had significantly higher incidences of di-
arrhea, failure to thrive and cutaneous symptoms
(Fig. 3). The positive rates of fecal eosinophils were
significantly higher in the early onset group (91% vs.
62%, p < 0.05). The results of the specific IgE test and
LST did not differ significantly between the groups.
There were no significant differences in gestational
age, birth weight, routine blood tests and stool tests
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Fig.　2　Comparison of clinical manifestations (A) and gastrointestinal symptoms (B) according to birth weight. 
The incidences of symptoms are shown as percentages. *p < 0.05 by Fisher exact test.
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Fig.　3　Comparison of clinical manifestations (A) and gastrointestinal symptoms (B) according to onset age in 
days. The incidences of symptoms are shown as percentages. Early onset, development of symptoms ≤6 days 
after birth; Late onset, development of symptoms ≥7 days after birth. *p < 0.05 by Fisher exact test.
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between neonates who were specific IgE-positive
(class 1 or higher, n = 29) and -negative (n = 69) or
between the specific IgE-positive group and the LST-
positive group (n = 21). The LST-positive group had a
significantly higher incidence of vomiting and ab-
dominal distension (p < 0.05). The incidence of cuta-
neous symptoms was 17% in the IgE-positive group,
compared to 4% and 5% in the IgE-negative and LST-
positive groups, respectively, with a significant differ-
ence between the IgE-positive and LST-positive
groups.
The median onset time in 10 cases in which gastro-
Food-Related Symptoms in Neonates
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enterological surgery was performed prior to onset
was 24 days (range: 7-47 days). Five of these cases
(50%) showed failure to thrive, a significantly higher
incidence than that in all other subjects (p < 0.05).
Among the 10 cases, all 3 tested for fecal eosinophils
were negative, but 5 cases (50%) were positive in a
specific IgE test, which was significantly higher than
the positive rate in all other subjects (p < 0.05).
DISCUSSION
The incidence of gastrointestinal symptoms is high in
cases of CMA that develop in early infancy.1-6 The re-
sults in this study suggest that this tendency is
stronger in CMA during the neonatal period. Since
these symptoms can also be seen in other diseases
and milk-specific IgE is typically not detected in neo-
nates who are allergic to cow’s milk, an OFC test
should be the sole basis for diagnosis of CMA. How-
ever, an OFC has a potential risk of worsening the
baby’s condition and cannot be performed for all
cases, especially after premature birth or in a case
with a severe underlying medical condition. Indeed,
CMA was mainly suspected only on the basis of a
positive milk elimination test in our study. Thus, the
neonates in this study had suspected CMA without
fulfilling the exact diagnostic criteria for food allergy;
therefore, these cases may include neonates with
food intolerance or eosinophilic diseases.
Neonates with birth weight <1000 g tended to de-
velop symptoms later than other birth weight groups.
In these neonates, the incidence of mild gastrointesti-
nal symptoms, such as abdominal distention or in-
creased gastric residual, was relatively high, and the
incidence of bloody stool was very low. Thus, CMA
may not be suspected until a neonate has developed
failure to thrive. Also, life-threatening complications
specific to premature infants, such as respiratory dis-
tress syndrome and patent ductus arteriosus, may
mimic symptoms of CMA.7,8
A high incidence of CMA after gastroenterological
surgery has been reported,9 and we also found 10
cases in which gastroenterological surgery was per-
formed prior to development of symptoms. Because
the recurrence of symptoms was not confirmed by
OFC, these symptoms cannot be clearly distin-
guished from transient symptoms caused by surgical
stress. However, interestingly, these cases showed a
high positive rate for specific IgE, which suggests
their sensitization mechanism may differ from that in
cases of common CMA. The mechanistic link be-
tween gastroenterological surgery and CMA develop-
ment is unknown, but may be associated with dys-
function of the gastrointestinal tract resulting from
primary diseases, surgical invasion of the gastrointes-
tinal tract, and atrophy in the intestinal mucosa
caused by extended fasting before and after surgery.9
Cases of CMA that developed after a long-term ele-
mental diet for postoperative short bowel syndrome
have also been described. This diet is assumed to
produce atrophy in the intestinal mucosa, enterocoli-
tis combined with abnormal distension in the remain-
ing gastrointestinal tract, and abnormal proliferation
of intestinal flora, thereby resulting in increased pro-
tein permeability in the intestinal mucosa.10,11
Most of the cases were receiving formula or com-
plementary feeding at onset, but there were some
cases with breastfeeding only. Low levels of proteins
in cow’s milk and other dairy products consumed by
the mother may transfer to breast milk12 and serve as
a causative antigen.13 Schulmeister et al. detected IgE
antibodies against breast milk proteins in >80% of pa-
tients with IgE-mediated CMA from infancy through
adulthood.14 A similar cross reaction may be involved
in development of CMA in neonates.
Powell and Sicherer et al. proposed the concept of
food protein-induced enterocolitis syndrome (FPIES)
as a non-IgE-mediated gastrointestinal allergy that de-
velops in early infancy.15-17 Typical FPIES is non-IgE
mediated, but atypical FPIES with elevated IgE anti-
bodies has also been reported and these patients less
easily acquire tolerance for milk with age.16,17 In our
study, milk-specific IgE was detected in only 30% of
cases. Thus, a test for specific IgE alone is likely to be
insufficient for diagnosis of CMA in neonates. How-
ever, it is possible that CMA with an increased level
of IgE antibodies may follow a similar course, and
awareness of this issue is important.
Several institutions in Japan have recently reported
that the LST is useful for diagnosis of delayed type
food allergy.13,18-20 The LST-positive rate was 80% in
our study, which supports the utility of this test. How-
ever, a LST tended not to be performed for antigen-
specific IgE positive cases, and the LST may be
viewed as a secondary test that is performed in cases
that are antigen-specific IgE-negative. This is because
the LST requires a higher blood sample volume and
is not currently available on a commercial basis. Sev-
eral reports have also shown that there is no signifi-
cant difference in the results of the LST between IgE-
mediated and non-IgE-mediated CMA.21 Thus, fur-
ther evaluation of the sensitivity and specificity of the
LST is needed in a large population.
Tests for fecal eosinophils are commonly con-
ducted for cases with food-related gastrointestinal
symptoms suggestive of CMA and the positive rate
may reach 70%, which suggests that this is a useful
test to screen for CMA2,4,15 and to evaluate the dis-
ease condition and the effects of treatment. However,
the results should be used carefully because the test
may be positive even in normal neonates in early in-
fancy.22 High levels of inflammatory reactions and
liver dysfunction have also been described in neo-
nates in previous reports.13,19 Cases with high CRP
tend to develop clinical manifestations such as fever
and not doing well, making differential diagnosis
from severe infection difficult.
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In Japan, most neonates with suspected CMA are
treated by neonatologists who tend to avoid conduct-
ing an OFC due to the risk of inducing serious symp-
toms. However, Host et al. found that OFC-induced
allergic symptoms occurred in only one-third of neo-
nates with gastrointestinal symptoms that suggested
CMA.23 Most neonates with food-related symptoms
suggestive of CMA develop gastrointestinal symp-
toms and few develop shock symptoms, as revealed
in the current study, which suggests that there is a
low risk of inducing serious immediate symptoms in
an OFC test, at least in cases with only mild gastroin-
testinal symptoms at the onset.
We confirmed that clinical manifestations of food-
related symptoms suggestive of CMA in neonates
were distinctly different from those of common im-
mediate type food allergies and that these manifesta-
tions were largely affected by underlying complica-
tions such as prematurity and gastroenterological
surgery. Further OFC-based prospective accumula-
tion of cases of CMA in neonates will be particularly
important to reveal the full clinical features of this dis-
ease.
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